Safety and Immunogenicity of PRO-169 in Patients With Diabetic Macular Edema

Clinical trial NCT07429474 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07429474
Sponsor: Laboratorios Sophia S.A de C.V.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Immunogenicity Anti-drug Antibodies (ADAs)

Start date: 2026-03-01
Primary completion: 2026-12-15
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.